Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study

NCT03195010 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT03195010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03195010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Terminated
Start date
June 9, 2017
Completion date
December 21, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, b-cell non-hodgkin lymphoma, chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, hematologic and lymphocytic disorder, hematopoietic cell transplantation recipient, myelodysplastic syndrome, primary myelofibrosis, secondary myelofibrosis, t-cell non-hodgkin lymphoma, thrombocytopenia, venous thromboembolism